POM
POMDOCTOR LIMITED American Depositary Shares
NASDAQ: POM · HEALTHCARE · PHARMACEUTICAL RETAILERS
$0.91
-12.50% today
Updated 2026-09-28
Market cap
$7.68M
P/E ratio
—
P/S ratio
0.02x
EPS (TTM)
$-6.26
Dividend yield
—
52W range
$0 – $6
Volume
0.1M
POMDOCTOR LIMITED American Depositary Shares (POM) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 2
Last 2 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
When is the next earnings report?
Reporting date
June 30, 2026
Consensus EPS estimate
—
Fiscal period ending
2026-06-30
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.7%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+1.7%
2025-12-03
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-03 | $-1.91 | — | $4.66 | $4.74 | +1.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-06-30 | — | — | — | — | — |
| 2025-09-30 | $0.00 | $-1.91 | — | — | — |
| 2024-12-31 | $0.00 | $-1.49 | — | — | — |
Frequently asked questions
When does POMDOCTOR LIMITED American Depositary Shares report next earnings?
POMDOCTOR LIMITED American Depositary Shares (POM) is scheduled to report earnings on June 30, 2026.
Has POMDOCTOR LIMITED American Depositary Shares beaten earnings estimates?
POMDOCTOR LIMITED American Depositary Shares has beaten Wall Street EPS estimates in 0 of its last 2 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.
How does POM stock react to earnings?
POM has moved an average of +1.7% the day after earnings over its last 1 reports, finishing higher after 1 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.